Sam Altman is preparing to co-found a new company funded by OpenAI that will go up against Elon Musk's Neuralink.

Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

The feud between OpenAI CEO Sam Altman and onetime cofounder Elon Musk may soon escalate with news that the former is ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...

OpenAI is reportedly discussing a potential investment in a new startup that aims to compete with Elon Musk’s brain implant ...

Merge Labs will compete with Elon Musk’s Neuralink, which is developing computer interface chips designed to be implanted in ...

Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...

In a strategic move, OpenAI CEO Sam Altman is reportedly planning to invest in a brain implant startup, called Merge Labs, ...

The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...

The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...

Sam Altman is backing brain-computer interface startup Merge Labs to compete with Elon Musk’s Neuralink, aiming to advance human-AI connections.